Ausgabe 1/2008 Anti-angiogenic therapies are coming of age in clinical oncology and haematology
Inhalt (13 Artikel)
Angiogenesis as a therapeutic target in advanced breast cancer
- Review article
H. Stöger, K. Hegenbarth
Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations
- Review article
F. Grossi, A. Brianti, C. Defferrari, P. Pronzato
(Neo-)adjuvant chemotherapy in breast cancer – Trials, errors and new rationales from the SABCS 2007
- Congress report
P. Dubsky, M. Gnant
Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events
- Case report
A. Zabernigg, M. Erdel, R. Schranzhofer, K. Berek, K. Gattringer
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient
- Case report
M. Giovannini, V. Gregorc, M. G. Viganò, E. Roca, C. Lazzari, A. Spreafico, C. Belli, G. Citterio, G. Rossoni, G. Donadoni, A. Corti, E. Villa, F. C. Cappio